Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin
Giuseppe Molinaro, Massimo Cugno, Mélissa Perez, Yves Lepage, Nicole Gervais, Angelo Agostoni and Albert Adam
Journal of Pharmacology and Experimental Therapeutics October 2002, 303 (1) 232-237; DOI: https://doi.org/10.1124/jpet.102.038067
Giuseppe Molinaro
Massimo Cugno
Mélissa Perez
Yves Lepage
Nicole Gervais
Angelo Agostoni
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 303, Issue 1
1 Oct 2002
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin
Giuseppe Molinaro, Massimo Cugno, Mélissa Perez, Yves Lepage, Nicole Gervais, Angelo Agostoni and Albert Adam
Journal of Pharmacology and Experimental Therapeutics October 1, 2002, 303 (1) 232-237; DOI: https://doi.org/10.1124/jpet.102.038067
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin
Giuseppe Molinaro, Massimo Cugno, Mélissa Perez, Yves Lepage, Nicole Gervais, Angelo Agostoni and Albert Adam
Journal of Pharmacology and Experimental Therapeutics October 1, 2002, 303 (1) 232-237; DOI: https://doi.org/10.1124/jpet.102.038067
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement